Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSCOPENHAGEN, DENMARK. – June 30, 2021 – The Danish National Genome Center has entered into an agreement with IQVIA to deliver a Laboratory Information Management System (LIMS). The contract was awarded to IQVIA Denmark after a national bidding process lasting for more than a year.
The system that will support the Genome Center in managing genomes from patients is developed by IQVIA partner Sapio Sciences - a leading provider of Laboratory Management Systems based in the US. IQVIA Denmark will deliver consulting services in a contract period for four years.
IQVIA will deliver consulting services based on local knowledge and global expertise
IQVIA already collaborates with IQVIA England and has deep healthcare and life sciences domain expertise to manage and curate real-world data with advanced analytical technologies. Kenneth Mikkelsen, General Manager IQVIA Denmark elaborates on these capabilities and the opportunities with genomics data:
“We already have a solid foothold in the Danish Healthcare Sector serving several Government agencies and hospitals. We are very pleased to expand this foothold with an organization like The Danish National Genome Center that is on an extremely interesting journey, which is critical to accelerate treatment advancements for patients.”
IQVIA is globally committed to make a difference in healthcare and a strategic collaboration like this partnership with The Danish National Genome Center and Sapio Sciences will support the company in the advancement of patient care through better prevention, earlier diagnosis and more targeted treatment for patients in Denmark.
“Sapio is very pleased to partner with IQVIA in this important initiative at the DNGC. Exemplar’s unmatched informatics platform allowed Sapio to demonstrate its ability to meet the extensive requirements for this project during the rigorous system evaluation. The analytical and intelligent approach taken by DNGC throughout the vendor selection process serves as a model for other organizations to follow so vendors are required to prove they can meet important requirements by showing capabilities, instead of just describing them. said Kevin Cramer, Chief Scientist at Sapio Sciences. He added “IQVIA does great work, and we look forward to working closely with them going forward.”
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 74,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
About Sapio Sciences
Since 2007, Sapio Sciences has been a leading provider of LIMS, ELN and Scientific Data Management software enabling our customers to manage their laboratories, experiments, and scientific data efficiently and effectively.
Exemplar LIMS and ELN break new ground by providing a unified, science aware platform that also embodies integrated search and analytics, all reachable through its high performance, web-based user interface. Exemplar is in use at most of the world’s largest pharmaceutical companies a as well as leading diagnostic organizations.
Sapio has customers around the world. They include: BMS, AbbVie, GSK, Roche, Novartis, Baylor College of Medicine, Daichi Sanko, Sanofi and numerous other leading life sciences organizations.
Contacts
Nick Childs, IQVIA Investor Relations
+1.973.257.7144
Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)
+1.484.567.6732
Anmarie Hazelton, Sapio Sciences (ahazelton@sapiosciences.com)
+1.717.880.1265